AstraZeneca India

It is now the first anti-complement therapy authorised in India for the treatment of for atypical Haemolytic Uremic Syndrome(aHUS)…

The approval follows evidence from the Phase III LAURA trial, which demonstrated significant clinical benefits in delaying disease…

Durvalumab in combination with chemotherapy as neoadjuvant treatment, followed by Durvalumab as monotherapy after surgery, is…

AstraZeneca will retain the intellectual property rights to budesonide and formoterol fumarate dihydrate and will continue to be…

Mina Patel, Head of Operations, AstraZeneca India, finds that listening to mentees, giving constructive feedback, and not…

AstraZeneca completed the acquisition of Alexion in the year 2021 and is now expanding its portfolio globally to bring innovative…

Panchal has been with AstraZeneca for 19 years and began his career in India back in 2003 as a Brand Associate

The CDI team in Bengaluru, India, is a critical advancement to support a growing global portfolio, and build on internal data…

The drug, on top of standard of care, reduced the composite measure of worsening of renal function or risk of cardiovascular (CV)…

Qtern is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus (T2DM)